Koyfin Home > Directory > Health Care > Horizon Therapeutics > Levered Free Cash Flow (FCF)

Horizon Therapeutics Levered Free Cash Flow (FCF) Chart (HZNP)

Horizon Therapeutics annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2020.
  • Horizon Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2020 was $-38m a 558.56% decrease of -214m year over year
  • Horizon Therapeutics Levered Free Cash Flow (FCF) for the last 12 months ending September 09, 2020 was $168m a -109.68% decrease of -185m year over year
  • Horizon Therapeutics Annual Levered Free Cash Flow (FCF) for 2019 was $353m a 46.52% increase of 164m from 2018
  • Horizon Therapeutics Annual Levered Free Cash Flow (FCF) for 2018 was $189m a -165.96% decrease of -313m from 2017
  • Horizon Therapeutics Annual Levered Free Cash Flow (FCF) for 2017 was $502m a 53.00% increase of 266m from 2016
Other Cash Flow Metrics:
  • Horizon Therapeutics Cash Flow from Operations for the quarter ending December 12, 2018 was $109m a 155.94% increase of 170m year over year
  • Horizon Therapeutics Total Revenue for the quarter ending December 12, 2018 was $356m a 37.03% increase of 132m year over year
View Chart On Koyfin

Quarterly HZNP Levered Free Cash Flow (FCF) Data

09/2020$-38m
06/2020$223m
03/2020$-193m
12/2019$176m
09/2019$34m
06/2019$77m
03/2019$65m
12/2018$75m
09/2018$69m
06/2018$79m

Annual HZNP Levered Free Cash Flow (FCF) Data

2019$353m
2018$189m
2017$502m
2016$236m
2015$278m
2014$91m
2013$-16m
2012$-46m
2011$-24m
2010$-17m